Evidence map›Paper›PMID 8391270›Full record

ReviewMolecular neurobiology1993

Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.

C A Dyer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. A glycosynapse in myelin?Glycoconjugate journal · 2004
    Review
  6. Review
  7. Article
  8. Negative regulation of oligodendrocyte differentiation by galactosphingolipids.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1999
    Article
  9. Insertion of a retrotransposon in Mbp disrupts mRNA splicing and myelination in a new mutant rat.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1999
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

C A DyerDepartment of Biomedical Sciences, E. K. Shriver Center, Waltham, MA 02254.
Eunice Kennedy Shriver Center · US

Funding

PHS HHS 13413
6 · The paper itself

Abstract

Antibodies are increasingly being used as tools to study the function of cell surface markers. Several types of responses may occur upon the selective binding of an antibody to an epitope on a receptor. Antibody binding may trigger signals that are normally transduced by endogenous ligands. Moreover, antibody binding may activate normal signals in a manner that disrupts a sequence of events that coordinates either differentiation, mitogenesis, or morphogenesis. Alternately, it is possible that binding elicits either a modified signal or no signal. This article focuses on the cascade of events that occur following specific antibody binding to myelin markers expressed by cultured murine oligodendrocytes. Binding of specific antibodies to the oligodendrocyte membrane surface markers myelin/oligodendrocyte glycoprotein (MOG), myelin/oligodendrocyte specific protein (MOSP), galactocerebroside (GalC), and sulfatide on cultured murine oligodendrocytes results in different effects with regard to phospholipid turnover, Ca2+ influxes, and antibody:marker distribution. The consequence of each antibody-elicited cascade of events appears to be the regulation of the cytoskeleton within the oligodendroglial membrane sheets. The antibody binding studies described in this article demonstrate that these myelin surface markers are capable of transducing signals. Since endogenous ligands for these myelin markers have yet to be identified, it is not known if these signals are normally transduced or are a modification of normally transduced signals.

Indexed as

Myelin-Associated GlycoproteinSignal TransductionAnimalsAntibodiesAntigen-Antibody ReactionsAntigens, SurfaceCalciumCells, CulturedCytoskeletonGalactosylceramidesMembrane GlycoproteinsMembrane LipidsMiceMyelin-Oligodendrocyte GlycoproteinMyelin ProteinsMyelin SheathAntibodiesAntigens, SurfaceCalciumGalactosylceramidesMembrane GlycoproteinsMembrane LipidsMog protein, mouseMyelin-Associated GlycoproteinMyelin-Oligodendrocyte GlycoproteinMyelin ProteinsPhospholipidsReceptors, Cell SurfaceSulfoglycosphingolipids

Identifiers

PMID8391270
OpenAlexW2329172261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.